Zurcher Kantonalbank (Zurich Cantonalbank) Surface Oncology, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $32.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 21, 2022
SELL
$2.65 - $5.08 $15,529 - $29,768
-5,860 Closed
0 $0
Q4 2021

Feb 01, 2022
SELL
$4.73 - $7.9 $2,861 - $4,779
-605 Reduced 9.36%
5,860 $28,000
Q3 2021

Nov 15, 2021
BUY
$5.16 - $7.98 $258 - $399
50 Added 0.78%
6,465 $49,000
Q2 2021

Jul 30, 2021
BUY
$6.45 - $9.09 $1,715 - $2,417
266 Added 4.33%
6,415 $48,000
Q1 2021

May 03, 2021
BUY
$7.25 - $13.82 $44,580 - $84,979
6,149 New
6,149 $48,000

Others Institutions Holding SURF

# of Institutions
2
Shares Held
315K
Call Options Held
0
Put Options Held
0
View Full List

About Surface Oncology, Inc.

SURF Quotes by TradingView
  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email